ebomi
Colour theme
Sign in
Insider · CIK 0001285644

Altomari Alfred

CIK 0001285644 Name as filed on the most recent filing

Filed as Altomari Alfred (23)

23 transaction lines · from 23 filings · filed 2007-05-10 to 2022-08-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

23 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-08-26 P, Open-market purchase Agile Therapeutics IncAGRX 22,500, acquired Open Form 4 filing 0001104659-22-095384
2021-10-13 P, Open-market purchase Agile Therapeutics IncAGRX Not reported Open Form 4 filing 0001104659-21-126012
2021-07-29 P, Open-market purchase Agile Therapeutics IncAGRX 33,096, acquired Open Form 4 filing 0001104659-21-097783
2021-05-18 P, Open-market purchase Agile Therapeutics IncAGRX 32,200, acquired Open Form 4 filing 0001104659-21-069099
2021-03-23 P, Open-market purchase Agile Therapeutics IncAGRX 25,030, acquired Open Form 4 filing 0001104659-21-040396
2020-12-07 S, Open-market sale Insmed IncINSM 791,400, disposed Open Form 4 filing 0001104659-20-133640
2020-11-23 P, Open-market purchase Baudax Bio, Inc.BXRX 5,300, acquired Open Form 4 filing 0001192482-20-000795
2020-03-26 P, Open-market purchase Baudax Bio, Inc.BXRX 11,700, acquired Open Form 4 filing 0001192482-20-000259
2020-02-27 P, Open-market purchase Agile Therapeutics IncAGRX 27,100, acquired Open Form 4 filing 0001104659-20-026463
2019-06-10 P, Open-market purchase Agile Therapeutics IncAGRX 25,400, acquired Open Form 4 filing 0001104659-19-034790
2019-03-25 P, Open-market purchase Agile Therapeutics IncAGRX 38,500, acquired Open Form 4 filing 0001104659-19-019002
2019-03-25 P, Open-market purchase Agile Therapeutics IncAGRX 38,500, acquired Open Form 4 filing 0001104659-19-017469
2019-02-26 S, Open-market sale Insmed IncINSM 165,000, disposed Open Form 4 filing 0001127430-19-000040
2019-02-15 S, Open-market sale Insmed IncINSM 151,250, disposed Open Form 4 filing 0001127430-19-000032
2019-02-05 S, Open-market sale Insmed IncINSM 137,500, disposed Open Form 4 filing 0001127430-19-000029
2019-01-10 S, Open-market sale Insmed IncINSM 123,750, disposed Open Form 4 filing 0001127430-19-000025
2017-08-25 P, Open-market purchase Agile Therapeutics IncAGRX 33,400, acquired Open Form 4 filing 0001104659-17-054004
2017-05-11 P, Open-market purchase Agile Therapeutics IncAGRX 35,100, acquired Open Form 4 filing 0001104659-17-032097
2016-12-15 P, Open-market purchase Recro Pharma, Inc.REPH 9,825, acquired Open Form 4 filing 0001123292-16-003064
2015-06-02 P, Open-market purchase Agile Therapeutics IncAGRX 21,825, acquired Open Form 4 filing 0001104659-15-043013
2011-08-11 P, Open-market purchase Dusa Pharmaceuticals IncDUSA 8,119, acquired Open Form 4 filing 0001209191-11-043721
2010-08-05 P, Open-market purchase Dusa Pharmaceuticals IncDUSA 5,040, acquired Open Form 4 filing 0001209191-10-041322
2007-05-08 S, Open-market sale Auxilium Pharmaceuticals IncAUXL 199,890, disposed Open Form 4 filing 0001209191-07-029260

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 17
  • Open-market sale 6
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. ALTOMARI ALFRED, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001285644

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.